The role of somatostatin and octreotide in pancreatic surgery and in acute and chronic pancreatitis

Keyphrases

• Somatostatin 100%
• Acute Pancreatitis 100%
• Chronic Pancreatitis 100%
• Octreotide 100%
• Pancreatic Surgery 100%
• Exocrine Pancreatic Secretion 85%
• Abscess 28%
• Placebo 28%
• Multicenter Trial 28%
• Fistula 28%
• Postoperative Complications 14%
• Randomized Double-blind 14%
• Pancreatic Resection 14%
• Potent Inhibitor 14%
• Statins 14%
• Sepsis 14%
• Pancreas 14%
• Fluid Collection 14%
• Digestive Enzymes 14%
• Complication Prevention 14%
• Enzyme Inhibition 14%
• Enzyme Secretion 14%
• Whipple Resection 14%
• Postoperative Acute Pancreatitis 14%
• Prophylactic Effect 14%
• Placebo Groups 14%
• Patient Will 14%
• Postoperative Complication Rate 14%
• Long-acting Somatostatin Analogs 14%

Medicine and Dentistry

• Pancreatic Surgery 100%
• Chronic Pancreatitis 100%
• Acute Pancreatitis 100%
• Somatostatin 100%
• Octreotide 100%
• Pancreas Secretion 85%
• Placebo 42%
• Postoperative Complication 28%
• Fistula 28%
• Abscess 28%
• Malignant Neoplasm 14%
• Morbidity 14%
• Statin 14%
• Sepsis 14%
• Pancreatitis 14%
• Pancreaticoduodenectomy 14%
• Somatostatin Derivative 14%
• Enzyme Release 14%
• Enzymes 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Somatostatin 100%
• Chronic Pancreatitis 100%
• Acute Pancreatitis 100%
• Octreotide 100%
• Placebo 42%
• Abscess 28%
• Postoperative Complication 28%
• Enzymes 28%
• Fistula 28%
• Malignant Neoplasm 14%
• Pancreatitis 14%
• Morbidity 14%
• Statin (Protein) 14%
• Somatostatin Derivative 14%
• Sepsis 14%